# CellSure, L3C – FDA Inspection, Dec 8, 2023

Source: https://www.keypedia.com/records/fda_inspections/cellsure-l3c/2a9579b3-ecc6-4ac3-968f-41b2b44409af
Source feed: FDA_Inspections

> FDA inspection 1224419 of CellSure, L3C, December 08, 2023. Classification: Voluntary Action Indicated (VAI). 12 citations under 21 CFR parts 211 and 1271. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1224419
- Company Name: CellSure, L3C
- Inspection Date: 2023-12-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 12

## Related Documents

- [FDA Inspection 1147632 - 2021-08-02](https://www.keypedia.com/records/fda_inspections/cellsure-l3c/51e24b0d-7a09-4c20-890c-0239cbe803e3)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/creighton-t-tuzon/be0d09c0-59f4-48c3-9e3d-a1ceb2587e3e)
- [Issuing Officer](https://www.keypedia.com/people/emily-b-camire/dff5f4c6-bcbe-4ef1-ac0b-1b2701b311ef)

Company: https://www.keypedia.com/companies/cellsure-l3c/6133765e-3818-4bbf-8871-962046a40e8c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d